Skip to main content
Year archive

HLB Therapeutics Co.,Ltd. — 2022 filings

All 23 regulatory filings released by HLB Therapeutics Co.,Ltd. (115450) in 2022, sourced directly from the official regulator.

23 Filings
2022 Period
2022 filings (23)
Filing Released Lang
[기재정정]주식배당결정
Notice of Dividend Amount
2022-12-28 Korean
배당락(주식배당)
Notice of Dividend Amount
2022-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2022-12-21 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2022-12-19 Korean
주식배당결정
Notice of Dividend Amount
2022-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-12-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-10-17 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-06-16 Korean
전환가액의조정(제13회차)
Capital/Financing Update
2022-05-16 Korean
전환가액의조정(제14회차)
Share Issue/Capital Change
2022-05-16 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-28 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-18 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-18 Korean
[기재정정]주주총회소집공고
AGM Information
2022-03-15 Korean
주주총회소집결의
AGM Information
2022-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-11 Korean
기타시장안내(약명및영문명)(한글약명)
Regulatory Filings
2022-01-11 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2022-01-03 Korean